Every Second Matters for Mothers and BabiesTM—Uterine Balloon Tamponade (ESM-UBT) Every year, an estimated 130,000 women die from postpartum hemorrhage—uncontrolled blood loss from mothers during birth. This case study – the first in a series from the Launch and
Join us on Wednesday, July 22, 8 am EDT, for The Future of Maternal, Newborn, and Child Health Innovation, co-hosted by Duke University and SL@B. Registration available HERE. Despite significant progress globally, persistent challenges in maternal, newborn, and child health
By Sowmya Rajan Creating a lasting impact that addresses complex global health challenges needs more than a game-changing innovation. Strong partnerships are needed at every stage of the innovation’s growth trajectory, from ideation, to implementation and scale. Some of these
Continuous innovation in the Maternal and Newborn Child Health sector plays a crucial role in reducing maternal and neonatal mortality. As new products and services continuously crop up in this space, human capital becomes key in implementing and scaling these
By Andrea Taylor For social innovations, scaling is the key to impact. But how do these innovations scale, and how can funders, accelerators, and other partners accelerate that process? We took a close look at the experience of a sample
By Pratik Doshi, Research Assistant, Duke Global Health Innovation Center, MD Candidate at Duke University School of Medicine Joy Bhosai, Associate Director, Innovations in Healthcare and Duke Global Health Innovation Center Elina Urli Hodges, Assistant Director of Programs, Innovations in
